Mavunkel; Babu J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mavunkel; Babu J..The latest application filed is for "indole-type derivatives as inhibitors of p38 kinase".
- Mavunkel; Babu J. - Sunnyvale CA
- Mavunkel; Babu J. - Baltimore MD
| Patent | Date |
|---|---|
| Indole-type derivatives as inhibitors of p38 kinase Grant 7,488,744 - Chakravarty , et al. February 10, 2 | 2009-02-10 |
| Indole-type derivatives as inhibitors of p38 kinase Grant 7,304,048 - Mavunkel , et al. December 4, 2 | 2007-12-04 |
| Indole-type Derivatives As Inhibitors Of P38 Kinase App 20070232617 - Chakravarty; Sarvajit ; et al. | 2007-10-04 |
| INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE App 20070161649 - Mavunkel; Babu J. ; et al. | 2007-07-12 |
| Indole-type derivatives as inhibitors of p38 kinase Grant 7,238,712 - Mavunkel , et al. July 3, 2 | 2007-07-03 |
| Indole-type derivatives as inhibitors of p38 kinase Grant 7,220,763 - Chakravarty , et al. May 22, 2 | 2007-05-22 |
| Piperidine/piperazine-type inhibitors of p38 kinase Grant 7,214,679 - Mavunkel , et al. May 8, 2 | 2007-05-08 |
| Benzofuran derivatives as inhibitors of p38-.alpha. kinase Grant 7,189,726 - Mavunkel , et al. March 13, 2 | 2007-03-13 |
| Compounds and methods to treat cardiac failure and other disorders Grant 7,189,739 - Mavunkel , et al. March 13, 2 | 2007-03-13 |
| Azaindole derivatives as inhibitors of p38 kinase App 20050288299 - Mavunkel, Babu J. ; et al. | 2005-12-29 |
| Reagents for N-amination App 20050065344 - Mavunkel, Babu J. ; et al. | 2005-03-24 |
| Indole-type derivatives as inhibitors of p38 kinase Grant 6,867,209 - Mavunkel , et al. March 15, 2 | 2005-03-15 |
| Indole-type derivatives as inhibitors of p38 kinase Grant 6,864,260 - Mavunkel , et al. March 8, 2 | 2005-03-08 |
| Indole-type derivatives as inhibitors of p38 kinase App 20040142940 - Chakravarty, Sarvajit ; et al. | 2004-07-22 |
| Indole-type derivatives as inhibitors of p38 kinase App 20030195355 - Mavunkel, Babu J. ; et al. | 2003-10-16 |
| Indole-type derivatives as inhibitors of p38 kinase App 20030162970 - Mavunkel, Babu J. ; et al. | 2003-08-28 |
| Benzofuran derivatives as inhibitors of p38-alpha kinase App 20030158417 - Mavunkel, Babu J. ; et al. | 2003-08-21 |
| Indole-type derivatives as inhibitors of p38 kinase App 20030144520 - Mavunkel, Babu J. ; et al. | 2003-07-31 |
| Compounds and methods to treat cardiac failure and other disorders Grant 6,589,954 - Mavunkel , et al. July 8, 2 | 2003-07-08 |
| Compounds and methods to treat cardiac failure and other disorders App 20030073699 - Mavunkel, Babu J. ; et al. | 2003-04-17 |
| Inhibitors of p38-a kinase Grant 6,541,477 - Goehring , et al. April 1, 2 | 2003-04-01 |
| Compounds and methods to treat cardiac failure and other disorders Grant 6,448,257 - Mavunkel , et al. September 10, 2 | 2002-09-10 |
| Inhibitors of p38-a kinase App 20020115671 - Goehring, R. Richard ; et al. | 2002-08-22 |
| Inhibitors of p38-.alpha.kinase Grant 6,410,540 - Goehring , et al. June 25, 2 | 2002-06-25 |
| Compounds and methods to treat cardiac failure and other disorders Grant 6,340,685 - Mavunkel , et al. January 22, 2 | 2002-01-22 |
| Compounds and methods to treat cardiac failure and other disorders Grant 6,130,235 - Mavunkel , et al. October 10, 2 | 2000-10-10 |
| Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists Grant 4,889,860 - Rzeszotarski , et al. * December 26, 1 | 1989-12-26 |
| Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists Grant 4,760,069 - Rzeszotarski , et al. July 26, 1 | 1988-07-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 